MAGENSAFTRESISTENTE TABLETTE

European patent · EP2959892 · In force

Register entry

Publication number
EP2959892
Application number
EP14754975
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 21, 2014
Published
Dec 30, 2015
Granted
Sep 9, 2020
Protection ends at the latest
Feb 20, 2034
Next annual fee due
Feb 28, 2027
IPC classes
A61K 9/28 (2006.01)
A61K 9/32 (2006.01)
A61K 9/36 (2006.01)
A61K 31/606 (2006.01)
A61P 1/04 (2006.01)
Priority
JP 2013032759 22.02.2013
PCT application
PCT/JP2014/054104 21.02.2014
PCT publication
WO2014/129568 28.08.2014
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  2. Mar 1, 2025

    Change

    Published in Swissreg on 01.03.2025

  3. Oct 16, 2024

    Change

    Published in Swissreg on 16.10.2024

  4. Mar 1, 2024

    Change

    Published in Swissreg on 01.03.2024

  5. Nov 15, 2023

    Change

    Published in Swissreg on 15.11.2023

  6. Mar 6, 2023

    Change

    Published in Swissreg on 06.03.2023

  7. Sep 23, 2021

    Change

    Published in Swissreg on 23.09.2021

  8. Sep 9, 2020

    Granted

    Published in Swissreg on 09.09.2020

Parties

Holder

Zeria Pharmaceutical Co., Ltd

Zeria Pharmaceutical Co., Ltd.

10-11, Nihonbashi Kobuna-cho Chuo-ku, Tokyo 103-8351, JP

Inventor

RYU, Akio

Tokyo 103-8351, JP

OSADA, Miyako

Tokyo 103-8351, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.